Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Governments / India — Drugs Technical Advisory Board
Entity

India — Drugs Technical Advisory Board

Tracked across 2 events · 14 articles · First seen Dec 31, 2025 · Last active May 26, 2026

Sentiment
15
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (2)
2 20
Regulatory
India OTC Nicotine Therapy Access
Public health experts in India are urging the India — Drugs Technical Advisory Board to maintain over-the-counter access for 2 mg and 4 mg nicotine replacement therapies (NRTs). This recommendation, made at the Respire-2026 event…
Impact: The India — Drugs Technical Advisory Board is urged by public health experts to maintain over-the-counter access for 2 mg and 4 mg nicotine replacement therapies.
May 07, 2026 · 7 articles
4 10
Regulatory
India Bans High-Dose Nimesulide
Impact: The India — Drugs Technical Advisory Board was consulted before the ban on high-dose Nimesulide was implemented, indicating its role in drug regulation.
Dec 31, 2025 · 7 articles
NEWSDESK
Track India — Drugs Technical Advisory Board live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.